Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

U.S. Axiron Promotional Report 2016-2017 - Research and Markets

Research and Markets
Posted on: 07 Sep 17

The "Axiron 2016 U.S. Promotional Report" report has been added to Research and Markets' offering.

The 5 Key Questions Addressed by this Report:

  • How many physicians were reached by Axiron through personal promotion in 2016 and how does this compare to its peer set in the Hypogonadism markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend on each type of activity?
  • How does Eli Lilly's depth of coverage vary within key specialties (e.g., Urology and Endocrinology) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Axiron throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most detailed prescribers and top paid speakers for Axiron in 2016?

Data Sources and Methodology:

  • We leverage company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, 42 months of longitudinal data is available - covering payments to more than 900,000 U.S. healthcare professionals.
  • Over 3,900 paid interactions across 2,100 physicians made on behalf of Axiron were carefully examined to support our analysis. In addition, interaction data from 3 peer products (e.g. AndroGel, Aveed, and Testopel ) was leveraged to provide benchmarking and market insights.

For more information about this report visit

View source version on

Business Wire

Last updated on: 07/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.